{"id":21068,"date":"2026-05-14T16:40:35","date_gmt":"2026-05-14T15:40:35","guid":{"rendered":"https:\/\/lsacademy.site-dev.it\/?p=21068"},"modified":"2026-05-21T14:20:10","modified_gmt":"2026-05-21T13:20:10","slug":"pharma-drug-manufacturing","status":"publish","type":"post","link":"https:\/\/lsacademy.site-dev.it\/en\/pharma-drug-manufacturing\/","title":{"rendered":"Pharma drug manufacturing"},"content":{"rendered":"\n

Pharmaceutical drug manufacturing operates at the intersection of scientific innovation, regulatory compliance, and industrial-scale production where even minor deviations can compromise patient safety, trigger regulatory sanctions, and damage organizational reputation. The complexity of modern pharmaceutical manufacturing extends far beyond mixing ingredients and filling containers\u00e2\u20ac\u201dit encompasses sophisticated quality systems, validated processes, contamination control strategies, and comprehensive documentation frameworks that collectively ensure every dose delivered to patients meets stringent safety and efficacy standards.<\/p>\n\n\n\n

As global pharmaceutical markets expand and regulatory scrutiny intensifies, the gap between basic manufacturing competence and excellence has never been more consequential. Companies struggling with chronic deviation rates, regulatory observations, and quality costs often share a common weakness: inadequate workforce capabilities in fundamental manufacturing principles, GMP requirements, and quality system implementation. Conversely, organizations achieving consistent manufacturing excellence invest strategically in comprehensive training that builds not just procedural compliance but deep understanding of why requirements exist and how to implement them effectively.<\/p>\n\n\n\n

This focused exploration examines the critical elements of pharmaceutical drug manufacturing, the specialized training pathways that build manufacturing competence through online learning platforms, and the rigorous regulatory oversight including EMA auditing that shapes manufacturing standards across global markets. Whether you’re developing manufacturing expertise, building organizational capabilities, or preparing for regulatory inspections, understanding these interconnected elements provides the foundation for sustainable manufacturing success.<\/p>\n\n\n\n

Understanding pharmaceutical drug manufacturing fundamentals<\/strong><\/h2>\n\n\n\n

Pharmaceutical drug manufacturing transforms raw materials into finished dosage forms through carefully controlled processes that must consistently deliver products meeting predetermined quality specifications. Modern pharmaceutical manufacturing encompasses diverse production approaches from traditional batch manufacturing to emerging continuous manufacturing technologies, each requiring specialized knowledge and operational discipline to achieve regulatory compliance and product quality objectives.<\/p>\n\n\n\n

Core manufacturing operations and process control<\/strong><\/h3>\n\n\n\n

Solid dosage manufacturing represents the most common pharmaceutical production format, involving unit operations including dispensing and weighing, mixing and blending, granulation, compression, and coating. Each operation demands precise parameter control\u00e2\u20ac\u201dmixing times and speeds, granulation moisture levels, compression forces, coating temperatures\u00e2\u20ac\u201dwith deviations potentially impacting product quality attributes including content uniformity, dissolution, and stability. Manufacturing personnel must understand not just procedure steps but the scientific principles underlying each operation and how process variables interact to determine product quality.<\/p>\n\n\n\n

Sterile manufacturing introduces additional complexity through requirements for contamination control, environmental monitoring, and aseptic processing techniques that prevent microbial contamination during production. Cleanroom operations under Grade A and Grade B conditions require specially trained personnel who understand contamination sources, proper gowning procedures, aseptic technique, and behavioral requirements for working in controlled environments. The consequences of sterile manufacturing failures for patient safety demand rigorous training and competency verification exceeding requirements for non-sterile operations.<\/p>\n\n\n\n

Process validation provides documented evidence that manufacturing processes consistently produce products meeting quality standards. The lifecycle validation approach established in FDA’s 2011 guidance encompasses process design based on development knowledge, process qualification demonstrating commercial-scale capability, and continued process verification through ongoing monitoring. Manufacturing personnel must understand validation purposes, their role in qualification studies, and the importance of maintaining validated status through change control and performance monitoring.<\/p>\n\n\n\n

Equipment qualification ensures manufacturing equipment operates as intended through installation qualification, operational qualification, and performance qualification activities. Properly qualified equipment represents a prerequisite for process validation, as equipment failures or inadequate performance undermine process capability regardless of procedural adherence. Manufacturing teams must recognize qualification status implications and understand equipment limitations, maintenance requirements, and deviation reporting obligations when equipment performs outside specifications.<\/p>\n\n\n\n

Quality systems and GMP compliance<\/strong><\/h3>\n\n\n\n

Good Manufacturing Practices establish minimum requirements for pharmaceutical manufacturing covering personnel, facilities, equipment, materials, procedures, production controls, and laboratory controls. GMP compliance isn’t optional\u00e2\u20ac\u201dit represents legal requirements enforced through regulatory inspections and sanctions for violations. However, viewing GMP solely as compliance obligations misses the reality that robust GMP implementation drives operational excellence, reduces quality costs, and enables consistent product quality that supports patient safety and business success.<\/p>\n\n\n\n

Documentation and record-keeping provide the evidence base demonstrating GMP compliance, process control, and product quality. Batch production records document manufacturing operations, equipment used, materials consumed, in-process controls, and deviations encountered. Review and approval of batch records by qualified personnel ensures operations occurred as planned before product release. Many regulatory observations stem from documentation deficiencies\u00e2\u20ac\u201dincomplete records, inadequate investigations, missing signatures\u00e2\u20ac\u201dhighlighting the criticality of robust documentation practices.<\/p>\n\n\n\n

Deviation management systems ensure manufacturing departures from procedures or specifications are identified promptly, assessed for impact, investigated thoroughly, and addressed through corrective actions. Effective deviation management balances investigation rigor against operational needs, using risk-based approaches that focus resources on deviations with significant quality implications. Chronic deviation backlogs or recurring similar deviations indicate systemic problems requiring management attention beyond individual deviation correction.<\/p>\n\n\n\n

Change control processes evaluate proposed changes to facilities, equipment, processes, or materials for potential quality impact before implementation. Manufacturing changes without adequate evaluation create contamination risks, process performance issues, and validation status compromises. Personnel must understand when changes require formal evaluation, how to assess potential impacts, and the validation or verification requirements different change types trigger.<\/p>\n\n\n\n

LS Academy’s pharmaceutical manufacturing courses<\/a> provide comprehensive training in manufacturing operations, GMP requirements, and quality system implementation. Our expert instructors bring extensive pharmaceutical manufacturing experience, enabling practical insights that resonate with professionals facing real-world production challenges. Through our tailor-made approach, we design programs addressing specific manufacturing contexts, operational challenges, and organizational learning objectives rather than generic content disconnected from participant needs.<\/p>\n\n\n\n\"MevDev<\/a>\n\n\n\n

Good manufacturing practices course online<\/strong><\/h2>\n\n\n\n

Online GMP training has evolved from simple compliance videos into sophisticated learning experiences combining multimedia content, interactive elements, assessment tools, and practical applications that develop genuine competencies rather than superficial awareness. Well-designed online courses provide flexible, cost-effective training delivery while maintaining learning effectiveness through instructional design principles adapted to digital formats.<\/p>\n\n\n\n

Advantages and applications of online GMP training<\/strong><\/h3>\n\n\n\n

Accessibility and flexibility enable personnel to complete training around operational schedules, across geographic locations, and at individual learning paces. Manufacturing personnel working shift schedules can access training during available hours rather than coordinating classroom attendance. Global organizations deliver consistent training content across multiple sites and regions without travel logistics or instructor availability constraints. Self-paced modules allow learners to spend additional time on challenging concepts while advancing efficiently through familiar material.<\/p>\n\n\n\n

Cost efficiency compared to classroom training reduces travel expenses, instructor fees, and productivity loss from extended time away from operations. Organizations can train large workforces without proportionally increasing costs, making comprehensive training economically feasible. These savings enable more frequent refresher training and broader training access across organizational levels. However, cost advantages shouldn’t compromise training quality\u00e2\u20ac\u201deffective online training still requires instructional design expertise, content development investment, and learning technology infrastructure.<\/p>\n\n\n\n

Standardized delivery ensures all learners receive identical content presentations, reducing variability from instructor differences, delivery inconsistencies, or unintended content modifications. This standardization proves particularly valuable for multinational organizations needing consistent GMP training across diverse locations and cultures. Standard content also facilitates regulatory compliance demonstration through documented curricula and consistent assessment approaches.<\/p>\n\n\n\n

Tracking and compliance documentation through learning management systems provides automated enrollment, completion monitoring, assessment scoring, and reporting capabilities that manual systems struggle to match. Real-time visibility into training status enables proactive management of overdue training, compliance gaps, and competency verification requirements. Electronic records simplify regulatory inspection preparation and demonstrate systematic training approaches that inspectors increasingly expect.<\/p>\n\n\n\n

Designing effective online GMP courses<\/strong><\/h3>\n\n\n\n

Content organization and comprehensive coverage <\/strong>ensure learners receive thorough, systematic training in complex GMP topics that demand deep understanding rather than superficial exposure. LS Academy’s approach prioritizes comprehensive 3-4 hour courses that provide complete coverage of critical topics, enabling learners to develop integrated understanding of how different GMP elements interconnect. This in-depth format proves particularly effective for pharmaceutical professionals who need to grasp not just individual procedures but the underlying principles, regulatory rationale, and practical implementation strategies that fragmented, brief modules cannot adequately address. Comprehensive courses facilitate continuity of learning, enable complex case study analysis, and support the detailed discussions necessary for truly understanding pharmaceutical quality systems rather than simply memorizing procedural steps.<\/p>\n\n\n\n

Multimedia integration through videos, animations, graphics, and interactive elements enhances engagement and learning effectiveness beyond text-based content. Video demonstrations of aseptic technique or equipment operation provide visual learning opportunities difficult to replicate through text descriptions. Animations illustrate processes like API synthesis or tablet compression that learners cannot directly observe. However, multimedia should enhance rather than distract from learning objectives\u00e2\u20ac\u201dgratuitous effects undermine rather than support educational purposes.<\/p>\n\n\n\n

Interactive assessments throughout courses verify comprehension, reinforce learning, and identify knowledge gaps requiring additional attention. Questions embedded within content provide immediate feedback enabling course correction before proceeding. Scenario-based assessments requiring application rather than simple recall develop critical thinking alongside factual knowledge. Assessment results inform both individual competency status and course effectiveness, identifying content requiring enhancement or clarification.<\/p>\n\n\n\n

Practical application assignments connecting training to workplace responsibilities drive transfer from theoretical knowledge to operational competence. Assignments might include procedure reviews identifying GMP requirements, deviation case study analyses, or documentation exercises using actual organizational forms. Application-focused learning proves particularly important for GMP training where procedural compliance represents the ultimate objective rather than simply knowing requirements.<\/p>\n\n\n\n

Blending online and in-person training<\/strong><\/h3>\n\n\n\n

Foundational knowledge delivery through online modules establishes baseline understanding before in-person sessions, maximizing face-to-face time for advanced topics, hands-on practice, and interactive discussions. This flipped classroom approach uses each modality’s strengths\u00e2\u20ac\u201donline for efficient information transfer, in-person for experiential learning and complex problem-solving. Learners arrive at in-person sessions prepared, enabling immediate engagement with application rather than basic concept introduction.<\/p>\n\n\n\n

Hands-on skill development for tasks like aseptic technique, equipment operation, or analytical testing requires physical practice with observation and feedback that online formats cannot replicate. Effective blended programs identify competencies requiring hands-on demonstration, scheduling targeted in-person sessions for these critical skills while delivering supporting knowledge online. This focused approach reduces in-person time requirements while ensuring adequate practical skill development.<\/p>\n\n\n\n

Assessment strategies combine online knowledge verification with in-person competency demonstration through practical examinations, observed performance, or simulated situations. Online assessments efficiently evaluate factual knowledge and conceptual understanding. In-person assessments verify practical skills and decision-making capabilities under realistic conditions. Comprehensive competency verification requires both assessment types rather than relying solely on either approach.<\/p>\n\n\n\n

LS Academy’s pharmaceutical quality management system<\/a> training portfolio includes robust online components enabling flexible learning while maintaining the practical, application-focused approach our programs are known for. Our problem-solving methodology ensures online content addresses actual manufacturing challenges rather than theoretical frameworks, while our caring approach to learner development provides support resources and expert access that pure self-study cannot offer. With a 97% satisfaction rate across our training programs, we’ve demonstrated consistent ability to deliver effective learning experiences regardless of delivery format.<\/p>\n\n\n\n

Ema auditing manufacturing<\/strong><\/h2>\n\n\n\n

European Medicines Agency oversight of pharmaceutical manufacturing through auditing and inspection activities ensures GMP compliance across products marketed in the European Union. EMA inspections evaluate manufacturing sites, quality systems, and compliance status, with inspection outcomes influencing marketing authorization decisions, product supply continuity, and organizational regulatory standing. Understanding EMA inspection approaches and preparing effectively represents essential capability for manufacturers serving European markets.<\/p>\n\n\n\n

EMA inspection frameworks and focus areas<\/strong><\/h3>\n\n\n\n

Good Manufacturing Practice compliance assessment examines whether manufacturing operations meet EU GMP requirements as detailed in the EudraCLex Volume 4 guidelines and specialized annexes. Inspectors evaluate documentation, interview personnel, observe operations, and examine quality systems to assess compliance depth and sustainability. Recent EMA inspection trends show increased emphasis on data integrity, quality culture, and quality risk management alongside traditional manufacturing and quality control assessments.<\/p>\n\n\n\n

Quality system effectiveness evaluation goes beyond checking documented procedures to assess whether quality systems actually function as designed and drive meaningful quality assurance. Inspectors look for evidence of proactive quality culture, effective deviation management, appropriate change control, and continuous improvement beyond minimum compliance. Superficial quality systems existing primarily on paper without operational impact increasingly trigger regulatory concerns and follow-up actions.<\/p>\n\n\n\n

Data integrity verification has become a major EMA inspection focus following numerous deficiencies identified across pharmaceutical manufacturing. Inspectors examine electronic and paper records for evidence of ALCOA+ principles\u00e2\u20ac\u201dAttributable, Legible, Contemporaneous, Original, Accurate, plus Complete, Consistent, Enduring, and Available. Common data integrity deficiencies include inadequate audit trails, shared login credentials, uncontrolled blank forms enabling backdating, and insufficient raw data retention.<\/p>\n\n\n\n

Cleaning validation receives particular scrutiny given cross-contamination prevention importance. EMA inspectors evaluate cleaning validation protocols, analytical methods, acceptance criteria rationale, and ongoing cleaning verification. Health-based exposure limits providing scientific justification for residue limits receive close examination. Inadequate cleaning validation represents a common deficiency requiring corrective action before regulatory acceptance.<\/p>\n\n\n\n\"Hands-On<\/a>\n\n\n\n

Inspection preparation and response strategies<\/strong><\/h3>\n\n\n\n

Risk assessment identifying potential inspection vulnerabilities enables targeted remediation before regulatory visits. Mock inspections by internal auditors or external consultants simulate EMA inspection approaches, identifying documentation gaps, procedure weaknesses, or personnel knowledge deficiencies. Organizations should prioritize remediation based on patient safety risk, regulatory citation likelihood, and correction difficulty, addressing critical issues immediately while planning staged improvements for lower-priority findings.<\/p>\n\n\n\n

Documentation review ensures batch records, validation reports, deviation investigations, and other quality documentation demonstrate compliance and withstand inspector scrutiny. Common documentation deficiencies include incomplete investigations lacking root cause analysis, inadequate change control evaluation, missing validation data, or illegible handwritten entries. Systematic documentation review before inspections identifies and corrects these weaknesses while establishing review protocols preventing future issues.<\/p>\n\n\n\n

Personnel preparation through inspection awareness training helps employees understand inspection processes, their individual roles, and appropriate response to inspector questions. Designated coordinators should manage inspection logistics and communication while ensuring subject matter experts are available without overwhelming inspectors with excessive personnel. Practice sessions addressing likely inspector questions build employee confidence and ensure consistent, accurate responses.<\/p>\n\n\n\n

Continuous readiness rather than pre-inspection scrambling creates sustainable compliance and reduces inspection stress. Organizations maintaining GMP compliance as normal operating standard rather than pre-inspection emergency perform better during inspections and sustain compliance between regulatory visits. This readiness mindset requires leadership commitment, adequate resources, and quality culture prioritizing compliance over competing operational pressures.<\/p>\n\n\n\n

Frequently asked questions<\/strong><\/h2>\n\n\n\n
What are the most common GMP deficiencies found during manufacturing inspections?<\/strong><\/strong>

Common deficiencies include inadequate cleaning validation, data integrity issues, incomplete deviation investigations lacking root cause analysis, insufficient change control evaluation, inadequate personnel training and qualification documentation, and quality system weaknesses including ineffective CAPA. Many deficiencies reflect systemic quality system problems rather than isolated technical violations. Organizations should analyze regulatory inspection trends and warning letters to understand current agency focus areas and proactively address potential vulnerabilities.<\/p> <\/div>

How long does online GMP training take compared to classroom instruction?<\/strong><\/strong>

Well-designed online GMP training typically requires similar or slightly less time than equivalent classroom instruction due to elimination of administrative overhead, more efficient content delivery, and self-pacing enabling learners to advance through familiar material quickly while spending additional time on challenging concepts. A classroom course requiring eight hours might translate to 6-7 hours of focused online learning. However, training effectiveness matters more than duration\u00e2\u20ac\u201dshorter training that doesn’t develop actual competencies wastes time regardless of format.<\/p> <\/div>

What qualifications should pharmaceutical manufacturing trainers have?<\/strong><\/strong>

Effective trainers should combine current technical expertise in pharmaceutical manufacturing and GMP with training delivery skills and regulatory knowledge. Direct manufacturing experience provides credibility and enables practical examples. Regulatory affairs background helps trainers address compliance context. Formal training credentials like “train the trainer” programs develop delivery skills. However, deep subject matter expertise often matters more than training certifications when evaluating trainer qualifications for technical content.<\/p> <\/div>

How can manufacturers prepare for unexpected EMA inspections?<\/strong><\/strong>

Maintain continuous inspection readiness through robust quality systems, current documentation, trained personnel, and regular internal audits rather than relying on pre-inspection preparation. Develop inspection response protocols establishing roles, communication procedures, and documentation handling expectations. Conduct periodic mock inspections identifying vulnerabilities. Monitor regulatory trends and warning letters to understand current inspection focus areas. Organizations maintaining daily GMP compliance handle unexpected inspections confidently while those relying on pre-inspection preparation struggle regardless of advance notice.<\/p> <\/div>

What’s the difference between EMA and FDA manufacturing inspections?<\/strong><\/strong>

While both agencies assess GMP compliance, inspection approaches differ. FDA typically provides advance notice and conducts multi-day inspections with detailed documentation review. EMA member state authorities conduct inspections on EMA’s behalf using approaches varying somewhat across countries. EU inspections may be shorter but equally thorough. Both agencies increasingly focus on data integrity and quality systems. Companies operating globally must understand both frameworks and maintain compliance satisfying both regulatory systems’ expectations.<\/p> <\/div>

How often should GMP refresher training be conducted?<\/strong><\/strong>

Annual GMP refresher training represents standard industry practice and satisfies many regulatory expectations. However, training frequency should reflect role responsibilities, regulatory changes, organizational incidents, and competency assessment results. Manufacturing personnel in critical roles may warrant more frequent training, while stable operations with strong performance may support extended intervals for some personnel. Trigger-based training responding to deviations, procedure changes, or equipment modifications supplements scheduled refresher training.<\/p> <\/div>

Can online training satisfy all GMP training requirements?<\/strong><\/strong>

Online training can satisfy many GMP training requirements including foundational knowledge, regulatory awareness, and procedure understanding. However, hands-on competencies like aseptic technique, equipment operation, or cleanroom gowning require practical demonstration with observation that online formats cannot provide. Blended approaches combining online knowledge building with targeted hands-on practice typically satisfy GMP training requirements most effectively and efficiently. Regulatory expectations focus on demonstrated competency rather than delivery format.<\/p> <\/div> <\/div>\n\n\n\n

Achieving pharmaceutical manufacturing excellence<\/strong><\/h2>\n\n\n\n

Pharmaceutical drug manufacturing excellence requires the convergence of robust quality systems, validated processes, contamination control strategies, and\u00e2\u20ac\u201dmost critically\u00e2\u20ac\u201dcompetent personnel who understand GMP requirements and implement them effectively. Organizations investing strategically in manufacturing training build capabilities that drive regulatory compliance, operational efficiency, and product quality that separate industry leaders from struggling competitors.<\/p>\n\n\n\n

The evolution of online training technologies has democratized access to high-quality GMP education while reducing cost barriers that previously limited training reach. However, technology alone cannot ensure training effectiveness\u00e2\u20ac\u201dinstructional design expertise, practical content development, and assessment rigor determine whether online training develops genuine competencies or provides superficial compliance documentation without meaningful learning.<\/p>\n\n\n\n

LS Academy’s comprehensive approach to pharmaceutical manufacturing education addresses both technical requirements and practical implementation challenges through programs designed by experienced industry professionals. Our expert instructors combine manufacturing operations experience with GMP expertise and training delivery skills, creating engaging learning experiences that resonate with participants. Through realistic scenarios, case studies, and application-focused exercises, we develop capabilities that translate directly to improved manufacturing performance.<\/p>\n\n\n\n

Our caring attention to learner needs, combined with our engagement-focused delivery methodology, creates supportive environments where professionals develop both competence and confidence. Our problem-solving approach ensures training addresses actual organizational challenges rather than generic content, while our tailor-made methodology designs solutions aligned with specific manufacturing contexts and learning objectives.<\/p>\n\n\n\n

With 877 courses organized, 121 conferences delivered, and 13,389 professionals trained across pharmaceutical manufacturing and quality disciplines, LS Academy has established credibility as a trusted partner for organizations pursuing manufacturing excellence. Our 97% satisfaction rate reflects our commitment to practical, implementable training that drives measurable improvement and positions organizations for regulatory success.<\/p>\n\n\n\n

Contact LS Academy today to explore how our pharmaceutical manufacturing training can advance your organizational capabilities and support sustainable GMP compliance. Whether you’re building internal training programs, developing personnel for new roles, or preparing for regulatory inspections, our team is ready to design comprehensive training solutions that deliver results and position your organization for long-term success in pharmaceutical drug manufacturing.<\/p>\n","protected":false},"excerpt":{"rendered":"

Pharmaceutical drug manufacturing operates at the intersection of scientific innovation, regulatory compliance, and industrial-scale production where even minor deviations can compromise patient safety, trigger regulatory sanctions, and damage organizational reputation. The complexity of modern pharmaceutical manufacturing extends far beyond mixing ingredients and filling containers\u00e2\u20ac\u201dit encompasses sophisticated quality systems, validated processes, contamination control strategies, and comprehensive … Continued<\/a><\/p>\n","protected":false},"author":84,"featured_media":21069,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-21068","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/lsacademy.site-dev.it\/en\/wp-json\/wp\/v2\/posts\/21068","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lsacademy.site-dev.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lsacademy.site-dev.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lsacademy.site-dev.it\/en\/wp-json\/wp\/v2\/users\/84"}],"replies":[{"embeddable":true,"href":"https:\/\/lsacademy.site-dev.it\/en\/wp-json\/wp\/v2\/comments?post=21068"}],"version-history":[{"count":7,"href":"https:\/\/lsacademy.site-dev.it\/en\/wp-json\/wp\/v2\/posts\/21068\/revisions"}],"predecessor-version":[{"id":21126,"href":"https:\/\/lsacademy.site-dev.it\/en\/wp-json\/wp\/v2\/posts\/21068\/revisions\/21126"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lsacademy.site-dev.it\/en\/wp-json\/wp\/v2\/media\/21069"}],"wp:attachment":[{"href":"https:\/\/lsacademy.site-dev.it\/en\/wp-json\/wp\/v2\/media?parent=21068"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lsacademy.site-dev.it\/en\/wp-json\/wp\/v2\/categories?post=21068"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lsacademy.site-dev.it\/en\/wp-json\/wp\/v2\/tags?post=21068"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}